Stem Cell Therapy Market, by Types (Autologous, and Allogeneic Stem Cell Therapy), by Application (Eye Diseases Oncology, Musculoskeletal Disorders, CNS Diseases, Metabolic Disorders, Wound & Injuries, CVS, and Immune System Disorders), by Cell Source (Adipose Tissue-Derived, Bone Marrow-Derived, and Embryonic Stem Cells), by End-Use, and by Geography (NA, EU, LATAM, APAC, and MEA) Analysis, Share, Trends, Size, & Forecast From 2020 2026
REPORT HIGHLIGHT
The stem cell therapy market was valued at USD XX billion by 2018, growing with XX% CAGR during the forecast period, 2020-2026
Market Dynamics
Stem cell therapy is a rapidly advancing branch of medicine that involves repair and regeneration of tissues to improve the organ function. This therapy has gained global recognition as one of the promising breakthroughs in natural healing and renewal. Stem cell therapy is used for the treatment of various life-threatening disorders such as diabetes, spinal cord injuries Parkinson’s & Alzheimer’s disease, cancer, heart disease, and osteoarthritis. Advancements and innovation in stem cell therapy has been trending subject in the past decade. Stem cell research also includes collecting data and using the data to benefit potential organ transplant patients.
One of the biggest applications of stem cell therapy is its use in organ transplant and tissue regeneration. According to the National Centre of Biotechnology Information (August 2017), cell therapy has been showing promising results in solid organ transplantation and is known to be safe and feasible in clinical trials. Thus, the demand for stem cell therapy is anticipated to increase in future. In addition to this, rising number for patients demanding organ transplantation support the industry growth. Based on data published in a National Stem Cell Foundation (NSCF), approximately 115,000 patients are on the waitlist for life-saving organ transplantation surgeries.
Furthermore, a transplant study led by DRI Federation center at Xiamen University in China and scientists from the Diabetes Research Institute at the Miller School showed that mesenchymal stem cells exhibits strong potential to replace a powerful anti-rejection therapeutics in transplant recipient. This study was published by the University of Miami Health System in February 2020. This benefits remains the key driver for the growth of the stem cell therapy industry. On the other side, unclear and ambiguous regulatory guidelines for stem cell research and application will pull back the industry growth to some extent.
Types Takeaway
In terms of types, the industry is segmented as autologous, and allogeneic stem cell therapy. Among these, the allogeneic stem cell therapy dominates the worldwide stem cell therapy market. The primary reason why allogeneic stem cell therapy governs this market is due to its wide range of applications and its ease of commercialization in clinical trials. An article published in ‘healio.com’ (December 2018) stated, that allogeneic therapy helps in reducing the risk of relapsed follicular lymphoma.
Application Takeaway
In terms of application, the stem cell therapy industry is broadly studied into CNS diseases, oncology, eye diseases¸ wound & injuries, musculoskeletal diseases, metabolic disorders, CVS and immune system disorders. Among the mentioned applications, the CNS category held the largest market share owing to the rising CNS disorders coupled with lack of effective treatment therapies. In November 2017, the article published by the Biopharma Dealmakers stated that there is a lack of successful curative therapies for the treatment of Alzheimer’s, Huntington’s, and Parkinson’s disease. This stem cell therapy has uplifted and firmly positioned its use to replace the damaged neurons thereby offers great hope for patients with neurodegenerative disorders.
Cell Source Takeaway
Based on the cell source segment, the industry is segmented into bone marrow-derived, adipose tissue-derived mesenchymal, and cord blood/embryonic stem cells. Within this category, the adipose tissue-derived segment accounted for maximum revenue share in 2018 and is projected to grow with promising growth rate during the forecast period. With respect to the fastest-growing category, bone marrow-derived means in mesenchymal stem cell leads undoubtedly. This cell source types are essential in providing support to the differentiation and growth of primitive hemopoietic tissues within the bone marrow microenvironment.
End-Use Takeaway
Hospitals and ambulatory surgical centres are the two end-users category analysed in this report. Among which, hospitals captured significant revenue share in 2018 and is anticipated to continue its dominance over the study period. Whereas, ambulatory surgical centres will be the fastest growing category during the projection period. Availability of centres such as Advanced Ambulatory Surgery Center (AASC) that offers world-class facility to physicians to perform stem cell procedures supports the segment growth to certain extent.
Regional Takeaway
Regionally, the North America is the most developed and dominant market with regards to stem cell therapy. This can be attributed to the rising research and development activity in the U.S market. Earlier, President Clinton had signed a law that banned Federal funding in research that was associated with destroying human embryos. In March 2019, then President Mr Obama issued an order that would favor the human embryonic stem cell research. In addition to this, as per the Charlotte Lozier Institute website (February 2018), approximately USD 131 million were allocated to human embryonic stem cell research whereas, 861 million dollar was attributed to non-embryonic stem cell research. Such favourable government initiatives would in turn help this region to grow considerably and provides path-breaking discoveries in the regenerative medicine category. The Asia Pacific follows the lead and is expected to be one of the fastest-growing markets over the forecast.
Key Vendor Takeaway
The key players that dominate the market in this category are, Mesoblast Ltd., Vericel Corporation, Gamida Cell, Stem Cells, Inc., Chiesi Farmaceutici S.p.A., Osiris Therapeutics, Inc. and ReNeuron Group, plc. Osiris therapeutics announced the completion of its acquisition by a Smith and Nephew PLC. In fact, in 2015, Chiesi Pharmaceutical drug that is an advanced stem cell therapy based medicinal product which is first of its kind was approved in Europe.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
- Mesoblast Ltd.
- Vericel Corporation
- Gamida Cell
- Stem Cells, Inc.
- Chiesi Farmaceutici S.p.A.
- Osiris Therapeutics, Inc.
- ReNeuron Group, plc.
MARKET, BY TYPES
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Therapy
MARKET, BY APPLICATION
- Eye Diseases
- Wound & Injuries
- Central Nervous System Diseases
- Cardiovascular Disorders
- Metabolic Disorders
- Oncology
- Musculoskeletal Diseases
- Immune System Disorders
MARKET, BY CELL SOURCE
- Cord Blood/Embryonic Stem Cells
- Adipose Tissue-derived Mesenchymal Stem Cells
- Bone Marrow-derived Mesenchymal Stem Cells
- Other Cell Sources
MARKET, BY END-USE
- Ambulatory Surgical Centers
- Hospitals
- Others
MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. STEM CELL THERAPY MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Type
2.1.2. Market Snippet by End Use
2.1.3. Market Snippet by Cell Source
2.1.4. Market Snippet by End Use
2.1.5. Market Snippet by Region
2.2. Competitive Insights
3. STEM CELL THERAPY KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. STEM CELL THERAPY INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. STEM CELL THERAPY MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. STEM CELL THERAPY MARKET – BY TYPE
6.1. Overview
6.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)
6.2. Autologous Stem Cell Therapy
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. Allogeneic Stem Cell Therapy
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. STEM CELL THERAPY MARKET – BY END USE
7.1. Overview
7.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
7.2. Eye Diseases
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Wound & Injuries
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Central Nervous System Diseases
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5. Cardiovascular Disorders
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.6. Metabolic Disorders
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.7. Oncology
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.8. Musculoskeletal Diseases
7.8.1. Overview
7.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.9. Immune System Disorders
7.9.1. Overview
7.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. STEM CELL THERAPY MARKET – BY CELL SOURCE
8.1. Overview
8.1.1. Segment Share Analysis, By Cell Source, 2019 & 2026 (%)
8.2. Cord Blood/Embryonic Stem Cells
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Adipose Tissue-derived Mesenchymal Stem Cells
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.4. Bone Marrow-derived Mesenchymal Stem Cells
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.5. Other Cell Sources
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. STEM CELL THERAPY MARKET – BY END USE
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2019 & 2026 (%)
9.2. Ambulatory Surgical Centres
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3. Hospitals
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4. Others
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10. STEM CELL THERAPY MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.2.4. North America Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
10.2.5. North America Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.2.6. North America Market Size and Forecast, By Cell Source, 2015 – 2026 (US$ Million)
10.2.7. North America Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.2.8. U.S.
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.2.9. Canada
10.2.9.1. Overview
10.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
10.3.5. Europe Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Cell Source, 2015 – 2026 (US$ Million)
10.3.7. Europe Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.3.8. Germany
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.10. United Kingdom
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.11. France
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.3.12. Rest of Europe
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Cell Source, 2015 – 2026 (US$ Million)
10.4.7. Asia Pacific Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.9. China
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.11. South Korea
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.4.12. Rest of APAC
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Cell Source, 2015 – 2026 (US$ Million)
10.5.7. Latin America Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.5.8. Brazil
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.9. Mexico
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.10. Argentina
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2015 – 2026 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Cell Source, 2015 – 2026 (US$ Million)
10.6.7. Middle East and Africa Market Size and Forecast, By End Use, 2015 – 2026 (US$ Million)
10.6.8. Saudi Arabia
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10.6.9. United Arab Emirates
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Mesoblast Ltd.
11.1.1. Company Snapshot
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiatives
11.2. Vericel Corporation
11.3. Gamida Cell
11.4. Stem Cells, Inc.
11.5. Chiesi Farmaceutici S.p.A.
11.6. Osiris Therapeutics, Inc.
11.7. ReNeuron Group, plc.
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Stem Cell Therapy market: Type Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Stem Cell Therapy market, by Type 2015-2026 (USD Million)
TABLE Stem Cell Therapy market: End Use Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by End Use
TABLE Global Stem Cell Therapy market, by End Use 2015-2026 (USD Million)
TABLE Stem Cell Therapy market: Cell Source Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Cell Source
TABLE Global Stem Cell Therapy market, by Cell Source 2015-2026 (USD Million)
TABLE Stem Cell Therapy market: End Use Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by End Use
TABLE Global Stem Cell Therapy market, by End Use 2015-2026 (USD Million)
TABLE Stem Cell Therapy market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Stem Cell Therapy market, by Region 2015-2026 (USD Million)
TABLE North America Stem Cell Therapy market, by Country, 2015-2026 (USD Million)
TABLE North America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
TABLE North America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE North America Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
TABLE North America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Europe Stem Cell Therapy market, by country, 2015-2026 (USD Million)
TABLE Europe Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
TABLE Europe Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Europe Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
TABLE Europe Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Asia Pacific Stem Cell Therapy market, by country, 2015-2026 (USD Million)
TABLE North America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
TABLE Asia Pacific Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Asia Pacific Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
TABLE Asia Pacific Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Latin America Stem Cell Therapy market, by country, 2015-2026 (USD Million)
TABLE Latin America Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
TABLE Latin America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Latin America Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
TABLE Latin America Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Middle East and Africa Stem Cell Therapy market, by country, 2015-2026 (USD Million)
TABLE Middle East and Africa Stem Cell Therapy market, by Type, 2015-2026 (USD Million)
TABLE Middle East and Africa Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
TABLE Middle East and Africa Stem Cell Therapy market, by Cell Source, 2015-2026 (USD Million)
TABLE Middle East and Africa Stem Cell Therapy market, by End Use, 2015-2026 (USD Million)
List of Figures
FIGURE Stem Cell Therapy market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Type segment market share analysis, 2019 & 2026
FIGURE Type segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Autologous Stem Cell Therapy market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Allogeneic Stem Cell Therapy market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Application segment market share analysis, 2019 & 2026
FIGURE Application segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Eye Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Wound & Injuries market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Central Nervous System Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cardiovascular Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Metabolic Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Oncology market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Musculoskeletal Diseases market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Immune System Disorders market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cell Source segment market share analysis, 2019 & 2026
FIGURE Cell Source segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cord Blood/Embryonic Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Adipose tissue-derived Mesenchymal Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Bone Marrow-derived Mesenchymal Stem Cells market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Other Cell Sources market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE End Use segment market share analysis, 2019 & 2026
FIGURE End Use segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Ambulatory Surgical Centers market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Hospitals market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Stem Cell Therapy market share and leading players, 2018
FIGURE Europe Stem Cell Therapy market share and leading players, 2018
FIGURE Asia Pacific Stem Cell Therapy market share and leading players, 2018
FIGURE Latin America Stem Cell Therapy market share and leading players, 2018
FIGURE Middle East and Africa Stem Cell Therapy market share and leading players, 2018
FIGURE North America Stem Cell Therapy market share analysis by country, 2018
FIGURE U.S. Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Stem Cell Therapy market share analysis by country, 2018
FIGURE Germany Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Stem Cell Therapy market share analysis by country, 2018
FIGURE India Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Stem Cell Therapy market share analysis by country, 2018
FIGURE Brazil Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Stem Cell Therapy market share analysis by country, 2018
FIGURE Saudi Arabia Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Stem Cell Therapy market size, forecast and trend analysis, 2015 to 2026 (USD Million)
